These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 2184899
21. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Maes M, Scharpé S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, Vanden Bossche BV, Cosyns P. Psychiatry Res; 1994 Nov; 54(2):143-60. PubMed ID: 7761549 [Abstract] [Full Text] [Related]
22. The relationships between the availability ofL-tryptophan to the brain, the spontaneous HPA-axis activity, and the HPA-axis responses to dexamethasone in depressed patients. Maes M, Minner B, Suy E. Amino Acids; 1991 Feb; 1(1):57-65. PubMed ID: 24194047 [Abstract] [Full Text] [Related]
23. Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Maes M, Wauters A, Verkerk R, Demedts P, Neels H, Van Gastel A, Cosyns P, Scharpé S, Desnyder R. Neuropsychopharmacology; 1996 Sep; 15(3):243-51. PubMed ID: 8873107 [Abstract] [Full Text] [Related]
24. The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and the relationships between post-dexamethasone cortisol and ACTH levels. Maes M, Minner B, Suy E. J Affect Disord; 1989 Sep; 17(1):39-46. PubMed ID: 2544636 [Abstract] [Full Text] [Related]
25. Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Maes M, Meltzer HY, Scharpé S, Bosmans E, Suy E, De Meester I, Calabrese J, Cosyns P. Psychiatry Res; 1993 Nov; 49(2):151-65. PubMed ID: 7908745 [Abstract] [Full Text] [Related]
26. Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression. Ormstad H, Dahl J, Verkerk R, Andreassen OA, Maes M. Eur Neuropsychopharmacol; 2016 Aug; 26(8):1286-96. PubMed ID: 27237997 [Abstract] [Full Text] [Related]
27. Computed tomography of the brain in unipolar depression. Van den Bossche B, Maes M, Brussaard C, Schotte C, Cosyns P, De Moor J, De Schepper A. J Affect Disord; 1991 Jan; 21(1):67-74. PubMed ID: 1827478 [Abstract] [Full Text] [Related]
28. Situational depression and the dexamethasone suppression test. Lesser IM, Rubin RT, Finder E, Forster B, Poland RE. Psychoneuroendocrinology; 1983 Jan; 8(4):441-5. PubMed ID: 6675036 [Abstract] [Full Text] [Related]
29. Decreased plasma tryptophan concentration in major depression: relationship to melancholia and weight loss. Anderson IM, Parry-Billings M, Newsholme EA, Poortmans JR, Cowen PJ. J Affect Disord; 1990 Nov; 20(3):185-91. PubMed ID: 2148339 [Abstract] [Full Text] [Related]
30. Influences on cortisol and noradrenergic turnover of healthy controls and depressed patients during L-tryptophan loading. Maes M, Vandevelde R, Suy E. J Affect Disord; 1989 Nov; 17(2):173-82. PubMed ID: 2549110 [Abstract] [Full Text] [Related]
31. A multivariate study of simultaneous escape from suppression by dexamethasone of urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and beta-endorphin in melancholic patients. Maes M, Vandervorst C, Suy E, Minner B, Raus J. Acta Psychiatr Scand; 1991 Jun; 83(6):480-91. PubMed ID: 1652880 [Abstract] [Full Text] [Related]
32. Symptom profiles of biological markers in depression: a multivariate study. Maes M, Maes L, Suy E. Psychoneuroendocrinology; 1990 Jun; 15(1):29-37. PubMed ID: 2114648 [Abstract] [Full Text] [Related]
33. Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients. Rothschild AJ, Benes F, Hebben N, Woods B, Luciana M, Bakanas E, Samson JA, Schatzberg AF. Biol Psychiatry; 1989 Oct; 26(6):565-75. PubMed ID: 2790096 [Abstract] [Full Text] [Related]
34. L-5-hydroxytryptophan stimulated cortisol escape from dexamethasone suppression in melancholic patients. Maes M, D'Hondt P, Martin M, Claes M, Schotte C, Vandewoude M, Blockx P. Acta Psychiatr Scand; 1991 Apr; 83(4):302-6. PubMed ID: 2028807 [Abstract] [Full Text] [Related]
35. Sex-linked differences in cortisol, ACTH and prolactin responses to 5-hydroxy-tryptophan in healthy controls and minor and major depressed patients. Maes M, Vandewoude M, Schotte C, Maes L, Martin M, Blockx P. Acta Psychiatr Scand; 1989 Dec; 80(6):584-90. PubMed ID: 2559587 [Abstract] [Full Text] [Related]
36. Evidence for the existence of major depression with and without anxiety features. Maes M, Meltzer HY, Cosyns P, Schotte C. Psychopathology; 1994 Dec; 27(1-2):1-13. PubMed ID: 7972633 [Abstract] [Full Text] [Related]
37. Pre- and postdexamethasone plasma ACTH and beta-endorphin levels in endogenous and nonendogenous depression. Rupprecht R, Barocka A, Beck G, Schrell U, Pichl J. Biol Psychiatry; 1988 Mar 01; 23(5):531-5. PubMed ID: 2830921 [No Abstract] [Full Text] [Related]
38. A clinical and biological validation of the DSM-III melancholia diagnosis in men: results of pattern recognition methods. Maes M, Maes L, Schotte C, Cosyns P. J Psychiatr Res; 1992 Jul 01; 26(3):183-96. PubMed ID: 1432845 [Abstract] [Full Text] [Related]
39. The dexamethasone suppression test in psychotic versus non-psychotic endogenous depression. Rihmer Z, Arató M, Szádoczky E, Révai K, Demeter E, György S, Udvarhelyi P. Br J Psychiatry; 1984 Nov 01; 145():508-11. PubMed ID: 6498417 [Abstract] [Full Text] [Related]
40. The dexamethasone suppression test in the clinical setting. Evans DL, Burnett GB, Nemeroff CB. Am J Psychiatry; 1983 May 01; 140(5):586-9. PubMed ID: 6342422 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]